Galenic formulations of organic compounds

Details for Australian Patent Application No. 2010209787 (hide)

Owner Novartis AG

Inventors Desset-Brethes, Sabine; Hirsch, Stefan

Agent Davies Collison Cave

Pub. Number AU-A-2010209787

PCT Pub. Number WO2010/086312

Priority 09151496.8 28.01.09 EP

Filing date 27 January 2010

Wipo publication date 5 August 2010

International Classifications

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

Event Publications

14 July 2011 PCT application entered the National Phase

  PCT publication WO2010/086312 Priority application(s): WO2010/086312

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010209790-Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives

2010209778-Method for dressing seeds